IRIS
PAOLILLO, CARMELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 480
NA - Nord America 297
AS - Asia 63
SA - Sud America 1
Totale 841
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 297
IE - Irlanda 220
SE - Svezia 116
UA - Ucraina 67
IT - Italia 46
CN - Cina 31
TR - Turchia 13
SG - Singapore 12
DE - Germania 10
FI - Finlandia 8
PL - Polonia 6
AT - Austria 2
FR - Francia 2
IN - India 2
PK - Pakistan 2
CL - Cile 1
ES - Italia 1
IR - Iran 1
NL - Olanda 1
RO - Romania 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
Totale 841
Salva come PNG Salva come JPEG
Città #
Dublin 220
Nyköping 90
Jacksonville 40
Ashburn 29
Chandler 24
Princeton 19
New York 16
Beijing 14
Kocaeli 13
Wilmington 13
Helsinki 8
Munich 8
Foggia 7
Singapore 6
Warsaw 6
Wuhan 4
Ginosa 3
Ann Arbor 2
Bologna 2
Des Moines 2
Guangzhou 2
Multan 2
Norwalk 2
Pune 2
San Severo 2
Bari 1
Dalian 1
Hanover 1
La Spezia 1
Los Angeles 1
Media 1
Melzo 1
San Lazzaro di Savena 1
Santa Clara 1
Shanghai 1
Totale 546
Salva come PNG Salva come JPEG
Nome #
Validation of a next-generation sequencing oncology panel optimized for low input DNA 66
Challenges in LC–MS-based metabolomics for Alzheimer’s disease early detection: targeted approaches versus untargeted approaches 56
Abstracts of the 2nd AMP Europe Congress 55
Single-cell genomics 53
Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples 51
Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients 50
Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine 48
Abstracts 48
Is quantitative real time polymerase chain reaction MCAM transcript assay really suitable for prognostic and predictive management of melanoma patients? 47
ERCC1 as biomarker of response to oxaliplatin in colorectal cancer: To induce or not induce … this is the problem. preliminary data from liquid biopsy 47
PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse 46
Absolute quantitative PCR for detection of molecular biomarkers in melanoma patients: A preliminary report 45
SARS-CoV-2 serological profile in healthcare professionals of a Southern Italy hospital 44
Detection of Activating Estrogen Receptor Gene (ESR1) Mutations in Single Circulating Tumor Cells 44
Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer 40
Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer 38
Circulating tumor cell-related transcripts in blood as prognostic biomarkers of early recurrence after liver resection for colorectal metastases 35
SARS-CoV-2 subgenomic N (sgN) transcripts in oro-nasopharyngeal swabs correlate with the highest viral load, as evaluated by five different molecular methods 34
Tandem mass spectrometry as strategy for the selective identification and quantification of the amyloid precursor protein Tyr682 residue phosphorylation status in human blood mononuclear cells 34
Is quantitative real time polymerase chain reaction MCAM transcript assay really suitable for prognostic and predictive management of melanoma patients? 22
Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platform 19
Spectrum of Germline BRCA1 and BRCA2 Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of Rome 14
Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic Isoforms 13
A Targeted Mass Spectrometry Approach to Identify Peripheral Changes in Metabolic Pathways of Patients with Alzheimer’s Disease 12
Analysis of annual distributions of hemoglobin A2 values as a method to test for HbA2 standardization 6
Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay 4
Totale 971
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.352
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 0 0 0 0 0 1 17 13 11 15 0
2020/2021155 13 0 13 0 16 0 15 30 40 27 0 1
2021/2022125 16 0 5 0 8 1 5 13 10 43 2 22
2022/2023471 43 17 19 3 8 22 5 42 248 3 16 45
2023/2024117 25 12 3 4 15 38 3 9 0 1 0 7
2024/202546 22 1 2 13 8 0 0 0 0 0 0 0
Totale 971